PPGN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PolyPeptide Group AG

Watchlist Manager

Watchlist

Price: 43.95 CHF 0.23% Market Closed

Market Cap: CHf1.5B

	PolyPeptide Group AG SIX:PPGN	CH
A	Abbott Laboratories XMUN:ABL	US
H	Heidelberg Materials AG MIL:1HEI	DE
C	Canadian Tire Corporation Ltd XBER:YAAA	CA

Profitability Summary

PolyPeptide Group AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

17%

Sustainable 3Y Average Gross Margin

11%

Gross Margin is Increasing

2% > 17%

Low Operating Margin

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-13% > 3%

Negative Net Margin

-5%

Negative 3Y Average Net Margin

-9%

Net Margin is Increasing

-13% > -5%

Negative Free Cash Flow Margin

-8%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-37% > -8%

Negative ROE

-6%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-6% > 2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.